The HCA LBO: How Bain and KKR De-Risked the Biggest Buyout of Its Era With $4.25B in Dividend Recaps

Dividend recaps have a bad reputation, and most of the reputation is earned. Ask an analyst what a recap looks like in practice and they'll usually tell you the Toys "R" Us story — sponsors loading up a fragile retailer with more debt to pay themselves a fee-plus-dividend, then walking away when the whole thing collapses on the LPs and the employees.

That story is real. It's also incomplete. In 2010, the same mechanic that ruined Toys "R" Us returned roughly 80% of the equity check on the largest LBO in US history — before the IPO had even happened. The deal was HCA. The sponsors were Bain Capital, KKR, and Merrill Lynch Global Private Equity, with the Frist family co-investing alongside. And the recaps worked because the underlying asset was a fundamentally different kind of business.

HCA is the mega-LBO of the 2006-2007 boom that actually worked. Not the biggest MOIC — Hilton claimed that trophy — but a genuinely successful $33B take-private in a vintage that mostly produced disasters (TXU, Chrysler, Harrah's, Clear Channel, Freescale). Worth understanding on its own terms, because the mechanism that made HCA a win was the same mechanism that made Toys "R" Us a wipeout. The mechanism didn't change. The asset did.

The deal, in numbers

The buyout was announced on July 24, 2006 and closed on November 17, 2006. Public shareholders were paid $51.00 per share in cash — about an 18% premium to HCA's closing price on July 18, 2006, the last trading day before the deal leaked. Here is the entry:

Two things about the entry are worth flagging before anything else.

First, the entry multiple. HCA cleared at around 7.2x on a forward EBITDA of ~$4.6B. That is a very different profile from the 21.7x that Blackstone paid for Hilton the following October — the deal we walked through in our Hilton peak-multiple case study. HCA was a boom-era mega-LBO priced closer to how you'd underwrite a mid-market deal today. When you enter at that kind of multiple, small operational wins compound into meaningful equity return; you don't need a heroic exit multiple to make the deal.

Second, the sponsor set. This wasn't a two-firm club deal — it was a founder-partner LBO. Dr. Thomas F. Frist Jr., whose family founded HCA in Nashville in 1968, co-invested with Bain, KKR, and Merrill Lynch's PE arm and retained roughly a 4.4% stake through close. That mattered for two reasons. One, hospitals are politically sensitive assets (state regulators, certificate-of-need boards, Medicare/Medicaid reimbursement politics), and having the founding family alongside gave the sponsors institutional cover the pure-financial version of the deal would not have had. Two, hospital operating knowledge is genuinely hard-won — Frist family alignment kept operational continuity intact rather than parachuting in a "value creation" playbook onto a business the sponsors didn't understand.

What HCA actually is

HCA is the largest for-profit hospital operator in the United States, currently running hundreds of hospitals and thousands of ambulatory care sites. The underwriting question in 2006 wasn't a growth question — it was a cash flow durability question. Do hospital cash flows show up whether the economy is up or down?

They do, and the reason is worth being specific about. Hospital revenue is largely non-discretionary — a patient with a broken arm or a heart attack does not defer treatment when consumer sentiment weakens. And on the payor side, revenue is diversified across Medicare, Medicaid, and commercial insurers, so a single-payor recession-driven shock doesn't collapse the top line. That combination — non-discretionary demand + payor diversification — makes for-profit hospitals a genuinely defensive credit in a way that consumer-discretionary retail, cyclical industrials, or commodity generation simply are not.

This is what let the sponsors underwrite a debt structure that would have been suicidal on a different asset. And within 18 months of close, the 2008-2009 recession put that thesis to the test. Consumer discretionary retail cratered. Auto sales fell off a cliff. Ad-dependent media businesses collapsed. HCA's admissions did not, and its cash flow held up well enough for the sponsors to do the thing that turns a good deal into a great one.

The 2010 dividend recap play

By early 2010 the deal was less than four years old, the recession was ending, and HCA's cash flow had proven itself through the downturn. The sponsors had a choice: exit through an IPO into a still-shaky equity market, or use the strengthening credit market to lever the company back up and dividend cash out to themselves.

They did both. Not sequentially — simultaneously. Over ten months in 2010, HCA ran three separate dividend recapitalizations:

That last recap in November was the tell. HCA had been on the IPO runway — an S-1 was on file — and the sponsors chose to take a third dividend instead of pricing the IPO into a market they didn't love. High-yield spreads were tight, investor appetite for a levered hospital operator's paper was strong, and the arithmetic of another recap simply beat the arithmetic of a rushed IPO.

Stack those three recaps and the math is striking. Roughly $4.25B was returned to sponsors in 2010 alone. On an original equity check of ~$5.3B, that is about 80% of the sponsors' capital back — before HCA had gone public, before the sponsors had sold a single share, and while they still owned the entire equity stack. Everything that came afterward — the March 2011 IPO, the follow-on sell-downs, the residual equity — was upside on a position the sponsors had already largely de-risked.

If you want the mechanic in more detail, we walk through the recap machinery in our dividend-recap primer built around the Toys "R" Us story. The interesting comparison is that the mechanic is identical — you re-lever the company, use the new debt to fund a dividend to equity holders, and now the company services a bigger debt stack going forward. The reason it turned HCA into a win and Toys "R" Us into a wipeout is entirely on the cash-flow side of the equation. Defensive hospital EBITDA absorbed the incremental leverage; cyclical retail EBITDA didn't. If you want to see the coverage math yourself — how much incremental interest a given EBITDA can actually service — the free debt capacity calculator makes the DSCR wall visible in seconds.

The 2011 IPO

By March 2011 the sponsors were ready. HCA priced its IPO on the NYSE on March 10, 2011:

At the time it was the largest US hospital IPO ever. The economics ran two directions. The primary tranche — 87.72M shares issued by HCA itself — netted the company about $2.506B, which management used largely to reduce credit-facility borrowings. The secondary tranche — 38.48M shares sold by the sponsors themselves — was the sponsors' first cash-out through the public market, on top of the $4.25B they had already pulled through the 2010 recaps.

Crucially, the IPO was a partial exit, not a full one. The sponsors continued to sell down their stakes through follow-on offerings over the next several years, and the residual equity kept appreciating as HCA compounded on the public market. Fortune's post-IPO analysis of Bain Capital alone reported a ~$1.2B gain on the firm's $64M direct investment, with Bain's LPs turning a $956M commitment into roughly $3.14B in proceeds — and that was measured at the IPO print, before most of the follow-on sell-down had happened. Roll the full sponsor group forward through the years of secondary sales and the total combined-sponsor profit is comfortably in the multi-billion range.

If you have never mapped a recap-plus-IPO-plus-sell-down waterfall onto a single MOIC and IRR, this is exactly the kind of multi-stage exit our LBO returns calculator exists to make concrete: dividend distributions during the hold, primary vs. secondary at IPO, and staggered follow-on sales all rolling up to one blended MOIC.

Why this deal worked and Toys "R" Us didn't

We wrote separately about how Hilton and Toys "R" Us produced opposite outcomes on similar-looking sources & uses tables, and HCA is the third data point in that comparison. Three mega-LBOs from the same vintage, three completely different outcomes:

• Toys "R" Us (2005): cyclical consumer discretionary + fragile margin + secular Amazon threat + aggressive recap → 0.0x MOIC and Chapter 11.
• Hilton (2007): defensive-ish hospitality + high entry multiple (21.7x) + peak-of-cycle timing + patient hold → 2.5x MOIC and one of the great deals in PE history.
• HCA (2006): genuinely defensive healthcare + conservative entry multiple (~7.2x) + aggressive recap + partial exit through IPO → strong multi-billion sponsor profit, roughly 80% of the equity check returned before the IPO even happened.

Pattern recognition: it wasn't the recap that killed Toys, and it wasn't the recap that saved HCA. In both cases the recap magnified the underlying business. Toys "R" Us on the incremental leverage couldn't cover its interest through the cycle. HCA on the incremental leverage could. If you flipped the assets and gave Toys "R" Us HCA's cash flow profile, the same $4.25B recap program would have worked there too. Underwriting the recap without underwriting the cash-flow durability is the mistake that keeps repeating.

The practical takeaway

A recap isn't good or bad in the abstract; it's a lever, and its effect is entirely determined by what it's attached to. Attached to defensive, non-discretionary cash flow — hospitals, essential services, contracted revenue — a recap can return the equity check ahead of the exit and let the IPO be pure upside. Attached to cyclical discretionary cash flow that can compress 20-30% in a recession, the same recap program pushes the company off the coverage cliff the moment the cycle turns.

Two questions to ask on any recap opportunity, and the point stands whether you're a sponsor sizing your own recap or an underwriter deciding whether to buy the new-issue paper. First, has the underlying business already proven its cash flow durability through a recession, or is that thesis untested? HCA had proven it by 2010 in a way Toys "R" Us never did. Second, does the incremental interest coverage still leave meaningful cushion under a downside case that flexes the real variable — for a hospital, that might be reimbursement rates; for retail, comparable-store sales; for a commodity producer, the price of the commodity — not just a generic 10% EBITDA haircut?

Our All-in-One PE Model is built to run exactly this kind of test: a full debt schedule with covenant tracking, a dividend-recap module you can flex on quantum and timing, and a returns waterfall that separates cash returned during the hold from proceeds at exit — so you can see, in one place, how much of a given MOIC came from a recap versus from the exit itself. See the sheet preview before you buy.

HCA didn't work because Bain and KKR discovered anything about recaps that other sponsors didn't know. Every mega-LBO firm knew the recap mechanic and had used it many times before. The reason HCA became the mega-LBO win of an otherwise brutal vintage is that the sponsors picked an asset whose cash flow could absorb the recaps they wanted to run — and then had the discipline to actually run them, on a schedule (three inside ten months) that pulled ~80% of their equity off the table before they ever had to touch the public equity market. On the biggest LBO in US history at the time of close, that is a very good way to sleep at night.

---

Sources:

1. HCA Healthcare press release, "HCA Completes Merger With Private Investor Group," Nov 17, 2006, investor.hcahealthcare.com — closing date, sponsor group composition, deal value
2. HCA Inc., Form 8-K exhibit — merger agreement announcement (Jul 24, 2006), sec.gov — $51/share price, ~18% premium, debt commitment banks
3. HCA Holdings, Inc. Form 10-K (FY2011), sec.gov — IPO primary share count, net proceeds, use of proceeds
4. HCA Healthcare press release, "HCA Announces Pricing of its Initial Public Offering," Mar 10, 2011, investor.hcahealthcare.com — IPO pricing and share count
5. HCA Holdings, Inc. Form 8-K — IPO pricing (Mar 2011), sec.gov — primary/secondary share allocation, net proceeds
6. Bloomberg, "HCA Rises in First-Day Trading After $3.79 Billion Offering," Mar 10, 2011, bloomberg.com — total offering size, first-day performance
7. Fortune, "How much did Bain REALLY make on HCA?" Mar 11, 2011, fortune.com — Bain Capital direct vs. LP economics
8. Bloomberg, "KKR, Bain to Take Third HCA Payout as Debt Looks Better Than IPO," Nov 9, 2010, bloomberg.com — November 2010 $2B recap and IPO deferral
9. Washington Post, "Hospital Chain Goes Private for $33 Billion," Jul 25, 2006, washingtonpost.com — announcement context, Frist family involvement
10. PitchBook, "This day in buyout history: KKR, Bain Capital complete the biggest LBO ever," pitchbook.com — ~$5.3B combined equity check figure
11. Bass, Berry & Sims PLC, "HCA — From Public Company to Private Company, and Back Again," bassberry.com — deal chronology